Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Carcinogenesis
|
April 1, 1992
DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls
D K Scates, A D Spigelman, R K Phillips, et al.
The British Journal of Surgery
|
August 1, 1990
Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis
A D Spigelman, C Crofton-Sleigh, S Venitt, et al.
Mutation Research
|
August 1, 1997
The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients
D K Scates, A D Spigelman, R K Phillips, et al.
Mutagenesis
|
July 1, 1993
Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase
C Crofton-Sleigh, A Doherty, S Ellard, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity
S Venitt, C Crofton-Sleigh, M Agbandje, et al.
Carcinogenesis
|
November 7, 1998
Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture
H Glatt, W Davis, W Meinl, et al.
Mutation Research
|
November 1, 1981
Sister-chromatid exchanges before and after hair dyeing
D J Kirkland, J R Honeycombe, S D Lawler, et al.
Carcinogenesis
|
June 1, 1993
DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls
D K Scates, A D Spigelman, K P Nugent, et al.
Mutation Research
|
September 3, 1998
Consideration of short-term carcinogenicity tests using transgenic mouse models
P G Blain, J M Battershill, S Venitt, et al.
Carcinogenesis
|
May 1, 1995
Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours
W Warren, P J Biggs, M el-Baz, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Carcinogenesis
|
April 1, 1992
DNA adducts detected by 32P-postlabelling, in the intestine of rats given bile from patients with familial adenomatous polyposis and from unaffected controls
D K Scates, A D Spigelman, R K Phillips, et al.
The British Journal of Surgery
|
August 1, 1990
Mutagenicity of bile and duodenal adenomas in familial adenomatous polyposis
A D Spigelman, C Crofton-Sleigh, S Venitt, et al.
Mutation Research
|
August 1, 1997
The use of 32P-postlabelling in studies of the nature and origin of DNA adducts formed by bile from patients with familial adenomatous polyposis and from normal patients
D K Scates, A D Spigelman, R K Phillips, et al.
Mutagenesis
|
July 1, 1993
Micronucleus assays using cytochalasin-blocked MCL-5 cells, a proprietary human cell line expressing five human cytochromes P-450 and microsomal epoxide hydrolase
C Crofton-Sleigh, A Doherty, S Ellard, et al.
Journal of Medicinal Chemistry
|
September 11, 1998
Anthracene-9,10-diones as potential anticancer agents: bacterial mutation studies of amido-substituted derivatives reveal an unexpected lack of mutagenicity
S Venitt, C Crofton-Sleigh, M Agbandje, et al.
Carcinogenesis
|
November 7, 1998
Rat, but not human, sulfotransferase activates a tamoxifen metabolite to produce DNA adducts and gene mutations in bacteria and mammalian cells in culture
H Glatt, W Davis, W Meinl, et al.
Mutation Research
|
November 1, 1981
Sister-chromatid exchanges before and after hair dyeing
D J Kirkland, J R Honeycombe, S D Lawler, et al.
Carcinogenesis
|
June 1, 1993
DNA adducts, detected by 32P-postlabelling, in DNA treated in vitro with bile from patients with familial adenomatous polyposis and from unaffected controls
D K Scates, A D Spigelman, K P Nugent, et al.
Mutation Research
|
September 3, 1998
Consideration of short-term carcinogenicity tests using transgenic mouse models
P G Blain, J M Battershill, S Venitt, et al.
Carcinogenesis
|
May 1, 1995
Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours
W Warren, P J Biggs, M el-Baz, et al.
Page
of 9